ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382050 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382050; 2) Community: the network communities that were significantly associated with the response to NSC 382050; 3) Molecule: the relationships between components within communities and NSC 382050; 4) MDR: the compounds that were significantly associated with the NSC 382050.

NSC Compound Enrichment Correlation
NSC 679024 1,8-Naphthyridin-4(1H)-one, 2-(4-fluorophenyl)-5-methyl- 0.0480633950058475 0.5588183
NSC 679516 Null 0.0480633950058475 0.35118104
NSC 685285 Null 0.0480633950058475 0.27219125
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.0480633950058475 0.32620868
NSC 6926 Null 0.0480633950058475 0.37367861
NSC 696073 Null 0.0480633950058475 0.13374399
NSC 711077 Null 0.0480633950058475 0.40043746
NSC 718781 Erlotinib hydrochloride 0.0480633950058475 -0.16633152
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0480633950058475 -0.044929624
NSC 726217 Combretastatin A4-analogue 0.0480633950058475 0.31433438
Total:98  Current:95    [First] [Prev] [Next] [Last]